First Mercantile Trust’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

First Mercantile Trust’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,200	Closed	-$136K	–	854
2017 Q2	$136K	Hold	1,200	–	–	0.02%	663
2017 Q1	$120K	Hold	1,200	–	–	0.02%	706
2016 Q4	$129K	Buy	+1,200	New	+$140K	0.02%	696

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

First Mercantile Trust's CBPO Position: Q3 2017 in Review

First Mercantile Trust sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 1,200 shares — an estimated $136K sold.

First Mercantile Trust first reported a position in CBPO in Q4 2016 and held it in 3 quarters. The position peaked at $136K in Q2 2017. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

First Mercantile Trust reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
First Mercantile Trust sold 1,200 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $136K.
First Mercantile Trust first reported a position in China Biologic Products Holdings, Inc. in Q4 2016 and held it in 3 quarters.
First Mercantile Trust's China Biologic Products Holdings, Inc. position peaked at $136K in Q2 2017.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on First Mercantile Trust's 13F filing for Q3 2017, filed 13 Nov 2017.